Benzinga | Aug 4, 2021 04:34PM EDT

Profound Medical Q2 EPS $(0.35) Misses $(0.26) Estimate, Sales $2.60M Beat $2.27M Estimate

Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.26) by 34.62 percent. This is a 23.91 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $2.60 million which beat the analyst consensus estimate of $2.27 million by 14.54 percent. This is a 82.97 percent increase over sales of $1.42 million the same period last year.